FDA approves Dr Reddy’s NDA for migraine drug
NEW DELHI: Dr Reddy’s Laboratories Ltd said the company’s NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been approved by the US Food and Drug Administration. Elyxyb (previously known as DFN-15), which is indicated for the acute treatment of migraine with or without aura in adults, is the latest product emerging from […]